NHS watch­dog im­pos­es $84M fine on Pfiz­er, Fly­nn Phar­ma in newest de­vel­op­ment of price-goug­ing saga

3 years ago
Pharma

Gilead dou­bles down on HIV pre­ven­tion, treat­ment amid Covid set­backs and await­ing FDA de­ci­sion on long-act­ing ...

3 years ago
Pharma
Marketing

Man­u­fac­tur­ing roundup: mR­NA man­u­fac­tur­er nets $300M+ in­vest­ment to scale re­search; Cy­ti­va ac­quires Michi­gan fa­cil­i­ty

3 years ago
Manufacturing

Biosim­i­lar in­spec­tions still lag­ging as the FDA looks to clear its back­log

3 years ago
FDA+
Manufacturing

The new CEO at Roche has fol­lowed a fa­mil­iar path in­to the C-suite. But it's his next steps that are cru­cial to his ...

3 years ago
Bioregnum

'Like a bul­let­proof vest': Can­cer cells make their own kind of col­la­gen. Can pierc­ing through make treat­ments bet­ter?

3 years ago
R&D
Discovery

Small UK biotech touts long-term da­ta for he­mo­phil­ia B gene ther­a­py as it at­tempts a come­back

3 years ago
R&D
Cell/Gene Tx

Covid-19 roundup: New Omi­cron sub­vari­ant first found in In­dia sparks de­bate on sever­i­ty; Ap­proval for Sh­ionogi's oral ...

3 years ago
Coronavirus

Up­dat­ed: Span­ish he­parin man­u­fac­tur­er draws the ire of the FDA in its lat­est warn­ing over qual­i­ty con­cerns

3 years ago
FDA+
Manufacturing

Con­nect with End­points News — here's our ma­jor event cal­en­dar com­ing up in H2 2022

3 years ago
Publisher's note

Roche trims out some pipeline fail­ures while flag­ging a PhI­II flop for Tecen­triq

3 years ago
R&D

Pfiz­er to make ma­jor in­vest­ment in vac­cine R&D and man­u­fac­tur­ing site in New York

3 years ago
R&D
Manufacturing

X4 slash­es pipeline, lays off staff just three weeks af­ter net­ting a $55M PIPE

3 years ago
People
R&D

Up­dat­ed: Study shows As­traZeneca's Covid-19 mAb Evusheld may not work against dom­i­nant Omi­cron strain

3 years ago
Coronavirus

One year af­ter leav­ing GSK, Em­manuel Hanon jumps to Medicxi-backed vac­cine start­up with an eye on RSV

3 years ago
Financing
Startups

John McHutchi­son throws in the tow­el on HBV drug, trig­ger­ing lay­offs as As­sem­bly shifts to next-gen ap­proach­es

3 years ago
People
R&D

Ver­tex taps Verve for gene edit­ing pact — buy­ing a chunk of shares — as Sek Kathire­san steers base edit­ing in­to ...

3 years ago
Deals
Cell/Gene Tx

Af­ter 14 years as Roche’s CEO, Sev­erin Schwan is pass­ing the ba­ton

3 years ago
People
Pharma

Val­neva's Covid-19 vac­cine con­tract with Eu­rope col­laps­es to just a frac­tion of the orig­i­nal deal

3 years ago
Coronavirus

No­vavax fo­cus­es on vari­ant-spe­cif­ic vac­cines in ex­pand­ed deal with South Ko­re­an man­u­fac­tur­er

3 years ago
Pharma
Coronavirus

Sen. Pat­ty Mur­ray urges HHS to ramp up mon­key­pox re­sponse as cas­es pass 2,100

3 years ago
Pharma

Pfiz­er, Gilead and oth­ers seek clar­i­fi­ca­tions on tri­al de­signs out­lined in FDA's UC and Crohn's draft guid­ance

3 years ago
Pharma

Medicare pays $700M+ an­nu­al­ly for dis­card­ed drugs. That's about to change

3 years ago
Pharma

Bris­tol My­ers launch­es pro­gram to make clin­i­cal tri­als more ac­ces­si­ble for peo­ple with dis­abil­i­ties

3 years ago
Pharma
First page Previous page 488489490491492493494 Next page Last page
A service from the Financial Times